Identification of 1α,25-Dihydroxyvitamin D3Response Elements in the Human Transforming Growth Factor β2 Gene
- 5 February 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 38 (9), 2654-2660
- https://doi.org/10.1021/bi981944s
Abstract
Transforming growth factor-β (TGF-β) is one of the most abundant growth factors secreted by bone cells, and regulation of TGF-β expression is crucial for bone development and growth. Previous studies from our laboratory demonstrated that 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) inhibits human osteoblast and keratinocyte growth by increasing TGF-β2 secretion and synthesis. To examine the mechanism by which 1α,25(OH)2D3 regulates TGF-β2 transcription in osteoblasts, we ligated segments of the human TGF-β2 promoter 5‘ of a growth hormone reporter gene in a growth hormone reporter plasmid and examined the effects of 1α,25(OH)2D3 administration on the expression of growth hormone in cells transfected with such chimeric promoter−reporter plasmids. The promoter region extending from −973 to +68 bp of the transcription start site elicited a 7-fold increase in reporter gene activity in transiently transfected osteoblasts after 1α,25(OH)2D3 treatment, whereas the region from −553 to +68 bp of the transcription start site showed no response following 1α,25(OH)2D3 treatment. Transfection of osteoblasts with reporter plasmids containing TGF-β2 promoter DNA from −869 to −658 bp revealed a 3.8-fold increase in reporter gene activity. DNA fragments from this region (−743 to −676 bp and −786 to −728 bp) ligated into reporter plasmids also showed increases in reporter activity. Gel retardation assay experiments showed that DNA fragments from −774 to −735 bp and −714 to −675 bp both formed a DNA−protein complex with bacterially expressed human retinoic acid X receptor α (RXRα) and vitamin D receptor (VDR) and with nuclear extracts from human bone cells. Addition of a vitamin D receptor antibody to reactions containing the aforesaid DNA fragments and bone cell nuclear extract resulted in further retardation of the mobility of the DNA−protein complex (super-shifting). Removal of two putative direct repeat DNA fragments in this region abolished VDR−RXRα−vitamin D response element complex formation. The TGF-β2 promoter contains two imperfect direct repeat DNA sequences: TGTAGAACAAGTAGA and AATGAAGTTGGTGGA that mediate the effect of 1α,25(OH)2D3.Keywords
This publication has 11 references indexed in Scilit:
- Development and characterization of a conditionally immortalized human fetal osteoblastic cell lineJournal of Bone and Mineral Research, 1995
- Two Vitamin D Response Elements Function in the Rat 1,25-Dihydroxyvitamin D 24-Hydroxylase PromoterPublished by Elsevier BV ,1995
- The Role of Cytokines and Growth Factors as Mediators of the Effects of Systemic Hormones at the Bone Local LevelCritical Reviews™ in Eukaryotic Gene Expression, 1995
- 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cellsMolecular Brain Research, 1994
- Interaction between retinoic acid and vitamin D signaling pathways.Journal of Biological Chemistry, 1993
- 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathwaysThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Intestinal Calcium Transport and Calcium Extrusion Processes at the Basolateral Membrane ,Journal of Nutrition, 1992
- The vitamin D story: a collaborative effort of basic science and clinical medicine 1The FASEB Journal, 1988
- Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitroJournal of Endocrinology, 1985
- Synthesis of deoxyoligonucleotides on a polymer supportJournal of the American Chemical Society, 1981